share_log

新銳醫藥:盈利預警

NEW RAY MEDIC: PROFIT WARNING

HKEX ·  Mar 14 12:31

Summary by Moomoo AI

新銳醫藥發佈盈利預警,預計截至2024年12月31日止年度將錄得虧損不少於3000萬港元,較2023財年約2220萬港元的虧損進一步擴大。公司表示,虧損擴大主要由於接近到期日的滯銷存貨導致存貨減值虧損約1310萬港元,較上年度的160萬港元大幅增加。虧損部分被按公平值計入損益的金融資產公平值收益所抵消,2024財年該項收益約390萬港元,較2023財年的40萬港元有所增加。公司預計將於2025年3月底刊發2024財年的詳細財務業績報告,目前披露的數據為初步評估結果,尚未經核數師審閱或審核。
新銳醫藥發佈盈利預警,預計截至2024年12月31日止年度將錄得虧損不少於3000萬港元,較2023財年約2220萬港元的虧損進一步擴大。公司表示,虧損擴大主要由於接近到期日的滯銷存貨導致存貨減值虧損約1310萬港元,較上年度的160萬港元大幅增加。虧損部分被按公平值計入損益的金融資產公平值收益所抵消,2024財年該項收益約390萬港元,較2023財年的40萬港元有所增加。公司預計將於2025年3月底刊發2024財年的詳細財務業績報告,目前披露的數據為初步評估結果,尚未經核數師審閱或審核。
NEW RAY MEDIC issued a profit warning, expecting to record a loss of no less than 30 million Hong Kong dollars for the year ending December 31, 2024, significantly larger than the loss of approximately 22.2 million Hong Kong dollars in the fiscal year 2023. The company stated that the loss expanded mainly due to inventory impairment losses of about 13.1 million Hong Kong dollars caused by unsold inventory approaching expiration, a substantial increase from last year's 1.6 million Hong Kong dollars.Part of the loss was offset by fair value gains from financial assets recognized at fair value in profit or loss, with an estimated gain of about 3.9 million Hong Kong dollars in fiscal year 2024, up from 0.4 million Hong Kong dollars in fiscal year 2023. The company anticipates releasing the detailed financial performance report for fiscal year 2024 by the end of March 2025; the disclosed figures are preliminary assessment results and have not yet been reviewed or audited by auditors.
NEW RAY MEDIC issued a profit warning, expecting to record a loss of no less than 30 million Hong Kong dollars for the year ending December 31, 2024, significantly larger than the loss of approximately 22.2 million Hong Kong dollars in the fiscal year 2023. The company stated that the loss expanded mainly due to inventory impairment losses of about 13.1 million Hong Kong dollars caused by unsold inventory approaching expiration, a substantial increase from last year's 1.6 million Hong Kong dollars.Part of the loss was offset by fair value gains from financial assets recognized at fair value in profit or loss, with an estimated gain of about 3.9 million Hong Kong dollars in fiscal year 2024, up from 0.4 million Hong Kong dollars in fiscal year 2023. The company anticipates releasing the detailed financial performance report for fiscal year 2024 by the end of March 2025; the disclosed figures are preliminary assessment results and have not yet been reviewed or audited by auditors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 395

Recommended

Statement

This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.